Cargando…

Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population

BACKGROUND: Shared decision-making (SDM), the process of engaging patients in their healthcare decisions, is an integral component of personalized medicine. The use of SDM in real-world allergy and asthma care in the United States (US) is unknown. Cross-sectional surveys of allergists and patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Eghrari-Sabet, Jacqueline, Williams, Dennis, Bukstein, Don A., Winders, Tonya, Gardner, Donna D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582489/
https://www.ncbi.nlm.nih.gov/pubmed/37859758
http://dx.doi.org/10.1016/j.waojou.2023.100828
_version_ 1785122343124729856
author Eghrari-Sabet, Jacqueline
Williams, Dennis
Bukstein, Don A.
Winders, Tonya
Gardner, Donna D.
author_facet Eghrari-Sabet, Jacqueline
Williams, Dennis
Bukstein, Don A.
Winders, Tonya
Gardner, Donna D.
author_sort Eghrari-Sabet, Jacqueline
collection PubMed
description BACKGROUND: Shared decision-making (SDM), the process of engaging patients in their healthcare decisions, is an integral component of personalized medicine. The use of SDM in real-world allergy and asthma care in the United States (US) is unknown. Cross-sectional surveys of allergists and patients in a US population were conducted to assess the use and perceptions of SDM and SDM tools in real-world allergy and asthma care. METHODS: Allergists (N = 101) who were members of the American College of Allergy Asthma & Immunology (ACAAI) and who were also Dynata (a marketing research firm) research partners or in the Allergy & Asthma Network customer database completed an online survey from February–March 2022. Adult patients (N = 110) with asthma, allergy, and/or eczema in the United States who were participants of online research panels hosted by Dynata completed on online survey from February 1–7, 2022. RESULTS: Based on their own definition, 98% of the allergists reported familiarity with SDM, and 79% reported using it frequently. Allergists reported using SDM with an average of 44% of their patients. The most commonly used tool was the Immunotherapy SDM toolkit (40%); 43% had not used any SDM tool. Among allergists not using SDM or using it infrequently (n = 19), 42% considered it too time-consuming and 37% believed their patients have low health literacy. Of the surveyed patients, 25% reported their provider used SDM “frequently” or “occasionally” when being treated for allergies, asthma, or eczema, and 22% reported using SDM tools with their provider at some point. The most commonly used tool was the Asthma and Allergy Symptom Test (60%). Among patients whose allergists used SDM infrequently or never (n = 56), 70% reported they would be likely to ask their allergist to use SDM more often. CONCLUSION: Survey responses revealed a disconnect between allergists and patients regarding SDM use. Barriers to SDM are consistent with those across the healthcare industry. Patients clearly expressed their desire for SDM.
format Online
Article
Text
id pubmed-10582489
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-105824892023-10-19 Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population Eghrari-Sabet, Jacqueline Williams, Dennis Bukstein, Don A. Winders, Tonya Gardner, Donna D. World Allergy Organ J Full Length Article BACKGROUND: Shared decision-making (SDM), the process of engaging patients in their healthcare decisions, is an integral component of personalized medicine. The use of SDM in real-world allergy and asthma care in the United States (US) is unknown. Cross-sectional surveys of allergists and patients in a US population were conducted to assess the use and perceptions of SDM and SDM tools in real-world allergy and asthma care. METHODS: Allergists (N = 101) who were members of the American College of Allergy Asthma & Immunology (ACAAI) and who were also Dynata (a marketing research firm) research partners or in the Allergy & Asthma Network customer database completed an online survey from February–March 2022. Adult patients (N = 110) with asthma, allergy, and/or eczema in the United States who were participants of online research panels hosted by Dynata completed on online survey from February 1–7, 2022. RESULTS: Based on their own definition, 98% of the allergists reported familiarity with SDM, and 79% reported using it frequently. Allergists reported using SDM with an average of 44% of their patients. The most commonly used tool was the Immunotherapy SDM toolkit (40%); 43% had not used any SDM tool. Among allergists not using SDM or using it infrequently (n = 19), 42% considered it too time-consuming and 37% believed their patients have low health literacy. Of the surveyed patients, 25% reported their provider used SDM “frequently” or “occasionally” when being treated for allergies, asthma, or eczema, and 22% reported using SDM tools with their provider at some point. The most commonly used tool was the Asthma and Allergy Symptom Test (60%). Among patients whose allergists used SDM infrequently or never (n = 56), 70% reported they would be likely to ask their allergist to use SDM more often. CONCLUSION: Survey responses revealed a disconnect between allergists and patients regarding SDM use. Barriers to SDM are consistent with those across the healthcare industry. Patients clearly expressed their desire for SDM. World Allergy Organization 2023-10-10 /pmc/articles/PMC10582489/ /pubmed/37859758 http://dx.doi.org/10.1016/j.waojou.2023.100828 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Eghrari-Sabet, Jacqueline
Williams, Dennis
Bukstein, Don A.
Winders, Tonya
Gardner, Donna D.
Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
title Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
title_full Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
title_fullStr Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
title_full_unstemmed Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
title_short Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
title_sort real-world use and perceptions of shared decision-making for allergy and asthma care in a us population
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582489/
https://www.ncbi.nlm.nih.gov/pubmed/37859758
http://dx.doi.org/10.1016/j.waojou.2023.100828
work_keys_str_mv AT eghrarisabetjacqueline realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation
AT williamsdennis realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation
AT buksteindona realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation
AT winderstonya realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation
AT gardnerdonnad realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation